"FreeSlate builds upon a tradition of enabling scientific R&D organizations to accelerate the pace of discovery while reducing costly, complex procedures that hinder efficiency," said John Senaldi, FreeSlate's chief executive officer.
Person Career
7th DIA Japan Annual Meeting
Submitted by mkeller on Mon, 08/03/2010 - 12:38Date(s) And Time(s):
Oct 28 2010 9:00AM - Oct 29 2010 5:00PM
Location:
Tower Hall Funabori
4-1-1 Funabori
Edogawa-ku
Tokyo
134-0091 Japan
Overview:
CONFERENCE OVERVIEW
1,200 jobs go with AstraZeneca closure
Submitted by Anonymous on Tue, 02/03/2010 - 16:19AROUND 1,200 jobs are to be lost with the closure of one of Loughborough's biggest employers.
AstraZeneca today announced it is to shut its pharmaceutical plant in the town next year.
Staff were told this afternoon.
Loughborough MP Andy Reed said: "The word devastating is over used but I think that is the only way to describe this."
Millipore Executive Payouts
Submitted by Anonymous on Tue, 02/03/2010 - 02:11Millipore insiders, Madaus eye big payouts
Boston Business Journal - by Craig M. Douglas
Monday, March 1, 2010, 2:12pm EST | Modified: Monday, March 1, 2010, 3:16pm
Business Roundtable with the Government of India (Indian Customers)
Submitted by bharatbookseo on Tue, 09/02/2010 - 05:23Business Roundtable with the Government of India (Foreign Customers)
To be held on March 16-17th, 2010 at the Maurya Sheraton, New Delhi
CTD Dossier Requirements Focus on EU Module 1 and Quality Module 4
Submitted by mkeller28 on Wed, 03/02/2010 - 11:48Date(s) And Time(s):
Mar 24 2010 8:00AM - Mar 25 2010 5:00PM
Location:
Taj Banjara
Road No. 1
Banjara Hills
Hyderabad 500034
Andhra Pradesh
India
Contact: http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?pr...
PFE Sandwich
Submitted by Anonymous on Tue, 02/02/2010 - 21:46Get shot of FTES and let the lab space!
Peakdale Molecular Partners With Pfizer
Drug Discovery & Development - February 01, 2010
22nd Annual EuroMeeting
Submitted by mkeller28 on Tue, 02/02/2010 - 12:38About the EuroMeeting
The Drug Information Association’s Annual EuroMeeting is global in scope, attracting well over 3,000 professionals from over 50 countries. It brings together professionals from the biopharmaceutical industry,contract service organisations, academic research centres, regulatory agencies and health ministries. The
Date(s) And Time(s):
Spectrum and Topotarget
Submitted by Anonymous on Tue, 02/02/2010 - 11:28- The Rumor Mill
- Biotechnology
- biotechnology
- California
- cancer
- Company Technology
- Company Ticker
- Conference Call
- FDA
- Irvine
- National Cancer Institute
- paclitaxel
- Peripheral T-Cell Lymphoma
- Person Career
- Quotation
- Spectrum Pharmaceuticals
- TopoTarget A/S
- TopoTarget Will Jointly Fund
- tumors
- U.S. Food and Drug Administration
Spectrum buying into cancer drug which is potential blockbuster. Not cheap, but probably worth it...
Spectrum Pharmaceuticals Licenses Belinostat, a Novel Anticancer Drug in a Pivotal Registrational Trial
•Belinostat, a HDAC Inhibitor, is Currently in a Multicenter, Registrational Trial Under a Special Protocol Assessment for Peripheral T-Cell Lymphoma (PTCL)
Lawsuit against TEVA's COPAXONE for a ALS clinical trial/misethical issues
Submitted by Anonymous on Fri, 29/01/2010 - 10:06Jan 29, 2010
On 22.1.2010 the following news article was published in the Israeli daily journal "yedioth aharonot"